Tetra Bio Pharma Inc (TBPMQ)

[Campeese]

Tetra Bio-Pharma files patent for treatment of cancer, ocular disease


Tetra Bio-Pharma Inc. (CSE: C.TBP, OTCQB: GRPOF, Forum) said Thursday it has submitted a provisional patent application with the U.S. patent and trademark office for a pharmaceutical drug formulation to treat various forms of cancer and ocular disease.

The global market for cancer drugs has hit US$100 billion in annual sales, and could reach US$147 billion by 2018, according to a new report by IMS Institute for Healthcare Informatics.


The Ontario-based company was in the news recently when it and and Aphria Inc. (TSX: V.APH, OTCQB: APHQF, Forum) announced plans for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.

Tetra and Aphria will enter into a joint supply agreement, the companies said in a press release.
Read more at http://www.stockhouse.com/news/newswire/2017/05/18/tetra-bio-pharma-files-patent-for-treatment-cancer-ocular-disease#v5bq4J20Y5Hzv1ck.99